These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4220613)

  • 1. Studies on fibrinogen fractions isolated from human plasma by precipitation with cold ether. I. Plasma kinin formation by the activation of contained plasminogen.
    Mackay M; Maycock WD; Silk E; Combridge BS
    Br J Haematol; 1965 Sep; 11(5):563-75. PubMed ID: 4220613
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on fibrinogen fractions isolated from human plasma by precipitation with cold ether. II. Enzymic acitivites resembling plasma kallikrein and C' I-esterase.
    Eisen V
    Br J Haematol; 1965 Sep; 11(5):576-85. PubMed ID: 5830027
    [No Abstract]   [Full Text] [Related]  

  • 3. A STANDARD CLOT METHOD FOR THE ASSAY OF PLASMINOGEN ACTIVATORS, ANTI-ACTIVATORS, AND PLASMIN.
    HAWKEY CM; STAFFORD JL
    J Clin Pathol; 1964 Mar; 17(2):175-81. PubMed ID: 14149945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CLINICAL TRIAL OF EPSILON-AMINOCAPROIC ACID IN SEVERE HAEMOPHILIA.
    GORDON AM; MCNICOL GP; DUBBER AH; MCDONALD GA; DOUGLAS AS
    Br Med J; 1965 Jun; 1(5451):1632-5. PubMed ID: 14295319
    [No Abstract]   [Full Text] [Related]  

  • 5. FIBRINOLYTIC THERAPY OF THROMBOEMBOLIC DISEASE.
    COON WW; PENNER JA
    Surg Gynecol Obstet; 1964 Sep; 119():495-502. PubMed ID: 14210147
    [No Abstract]   [Full Text] [Related]  

  • 6. THE INHIBITION OF TRASYLOL OF FIBRINOLYTIC ACTIVITY ASSOCIATED WITH CARDIOVASCULAR OPERATIONS.
    TICE DA; WORTH MH; CLAUSS RH; REED GH
    Surg Gynecol Obstet; 1964 Jul; 119():71-4. PubMed ID: 14179354
    [No Abstract]   [Full Text] [Related]  

  • 7. THROMBOLYTIC THERAPY.
    DOUGLAS AS; MCNICOL GP
    Br Med Bull; 1964 Sep; 20():228-32. PubMed ID: 14209763
    [No Abstract]   [Full Text] [Related]  

  • 8. ACTION OF THE NEW ANTI-FIBRINOLYTIC SUBSTANCE ON THE STREPTOKINASE-ACTIVATED PROTEASES (PLASMINS).
    MIHARA H
    Kobe J Med Sci; 1963 Dec; 18():169-77. PubMed ID: 14160537
    [No Abstract]   [Full Text] [Related]  

  • 9. Degradation of human fibrinogen by plasms alpha2-macroglobulin-enzyme complexes.
    Harpel PC; Mosesson MW
    J Clin Invest; 1973 Sep; 52(9):2175-84. PubMed ID: 4269529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. THE FORMATION OF CHONDROMUCOPROTEIN-FIBRINOGEN AND CHONDROMUCOPROTEIN-BETA-LIPOPROTEIN COMPLEXES.
    ANDERSON AJ
    Biochem J; 1963 Sep; 88(3):460-9. PubMed ID: 14071519
    [No Abstract]   [Full Text] [Related]  

  • 11. [The behavior of coagulation and fibrinolysis factors with different streptokinase doses].
    Poliwoda H; Krohn HP; Steuber H
    Med Lab (Stuttg); 1968 Nov; 21(11):252-61. PubMed ID: 5714595
    [No Abstract]   [Full Text] [Related]  

  • 12. STUDIES ON THE MOLECULAR PATHOLOGY AND PATHOGENESIS OF BLEEDING IN SEVERE FIBRINOLYTIC STATES IN DOGS.
    KOWALSKI E; BUDZYNSKI AZ; KOPEC M; LATALLO ZS; LIPINSKI B; WEGRZYNOWICZ Z
    Thromb Diath Haemorrh; 1964 Oct; 12():69-86. PubMed ID: 14224647
    [No Abstract]   [Full Text] [Related]  

  • 13. Kininogen in human plasma after fibrinolytic activation.
    Hamberg U
    Scand J Clin Lab Invest Suppl; 1969; 107():37-47. PubMed ID: 4246532
    [No Abstract]   [Full Text] [Related]  

  • 14. ACTIVATION OF PARTIALLY PURIFIED PLASMINOGEN IN THE PRESENCE OF EPSILON-AMINOCAPROIC ACID. A TECHNIQUE FOR PREPARING PLASMIN FREE OF EXTRINSIC ACTIVATORS.
    DONALDSON VH
    J Lab Clin Med; 1964 Feb; 63():213-23. PubMed ID: 14125108
    [No Abstract]   [Full Text] [Related]  

  • 15. THE LABORATORY CONTROL OF THROMBOLYTIC THERAPY.
    HAWKEY C; HOWELL M
    J Clin Pathol; 1964 May; 17(3):287-91. PubMed ID: 14159462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EFFECTS OF FIBRINOLYTIC AGENTS AND HEPARIN ON BLOOD COAGULATION IN DOGS.
    LEWIS JH; SHIRAKAWA M
    Am J Physiol; 1964 Nov; 207():1049-52. PubMed ID: 14237448
    [No Abstract]   [Full Text] [Related]  

  • 17. MECHANISM OF HUMAN PLASMINOGEN ACTIVATION BY STREPTOKINASE AND HUMAN PLASMIN.
    BLATT WF; GRAY JL; JENSEN H
    Thromb Diath Haemorrh; 1964 Apr; 11():85-93. PubMed ID: 14167118
    [No Abstract]   [Full Text] [Related]  

  • 18. Antagonistic action of urokinase to bradykinin- and plasminogen-induced capillary permeability.
    COPLEY AL; TSULUCA V
    Nature; 1963 Jan; 197():294-5. PubMed ID: 14022898
    [No Abstract]   [Full Text] [Related]  

  • 19. SOME PROPERTIES OF THE ANTIFIBRINOLYTICALLY ACTIVE ISOMER OF AMINO-METHYLCYCLOHEXANE CARBOXYLIC ACID.
    DUBBER AH; MCNICOL GP; DOUGLAS AS; MELANDER B
    Lancet; 1964 Dec; 2(7373):1317-9. PubMed ID: 14224037
    [No Abstract]   [Full Text] [Related]  

  • 20. [THROMBOLYTIC THERAPY AND CHANGES IN FIBRINOLYTIC ACTIVITY].
    DOUGLAS AS; MCNICOL GP
    Recenti Prog Med; 1964 Sep; 37():189-217. PubMed ID: 14229145
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.